Daniel Viriato

Daniel Viriato is a pharmaceutical executive with over a decade of experience in Commercial and Market Access roles. Currently serving as the Business Unit Head at Eli Lilly, they oversee oncology, neuroscience, and biomedicines. Previously, Daniel held key leadership positions at Novartis, including Oncology Business Unit Head and Global Market Access Director. They also have experience as the Country Head at Takeda Oncology and served as a Teacher Assistant at the Faculty of Pharmacy of the University of Lisbon. Daniel earned a Master's degree in Biostatistics from the Faculdade de Ciências da Universidade de Lisboa.